Skip to main content
. 2021 Dec 20;11:807171. doi: 10.3389/fonc.2021.807171

Table 5.

Signals of ADRs.

Drug ADR No. ROR 95% CI Lower limit PRR 95% CI Lower limit χ2
Vincristine Alopecia 4 63.39 10.64 48.71 10.90 327253.85
Asparaginase Cyanosis a 3 21.64 2.21 20.51 2.22 114461.47
Pegaspargase Itch a 3 17.29 2.79 15.97 2.82 94729.67
Methotrexate Mucositis oral 7 63.50 7.63 54.57 7.69 42646.14
Asparaginase Dyspnea 6 15.22 3.69 13.67 3.73 11950.02
Methotrexate Hepatic failure 4 6.70 1.74 6.24 1.75 11208.07
Pegaspargase Fibrinogen decreased 4 5.85 1.67 5.32 1.69 8295.83
Asparaginase Fibrinogen decreased 8 15.83 4.59 13.67 4.65 5071.55
Cyclophosphamide Reaction gastrointestinal 7 9.08 3.31 7.20 3.41 2756.44
Fludarabine Myelosuppression 3 17.02 1.74 5.00 3.74 1256.66
Cisplatin Vomiting 6 8.31 2.57 4.66 3.00 686.61
Etoposide Rash a 7 3.14 1.22 2.46 1.29 236.91
Pegaspargase Rash 13 4.00 1.91 2.95 2.01 73.08
Asparaginase Rash 18 3.87 2.02 2.93 2.12 25.59
a

Off-label ADR.